Mettrum Health Corp.
TSX VENTURE : MT
TSX VENTURE : MT.WT

Mettrum Health Corp.

August 31, 2015 08:30 ET

Mettrum Receives Cannabis Extraction License from Health Canada

Mettrum Begins Cannabis Extracts Production

TORONTO, ONTARIO--(Marketwired - Aug. 31, 2015) - Mettrum Health Corp. ("Mettrum" or the "Company") (TSX VENTURE:MT)(TSX VENTURE:MT.WT), a vertically integrated agri-pharmaceutical company focused on research, development, production and distribution of medical cannabis products, is pleased to announce that it has received a supplemental license from Health Canada for the production of cannabis extracts effective immediately.

"This furthers our commitment to provide physicians and their patients with alternative and convenient consumption methods for all of the products within the Mettrum Spectrum," said Michael Haines, President and CEO of Mettrum. "For people who use cannabis for their health, Mettrum is committed to helping them live their way by providing consistent high quality products, best-in-class service, and educational tools for our clients and the medical community. We are pleased to see our strategy unfold and continue to build value for all of our stakeholders."

The Health Canada supplemental license allows the Company to begin producing cannabis oils and resins. Shipping will commence once the Company receives an amendment by Health Canada that will permit the company to sell its derivative products.

About Mettrum Health Corp.

Mettrum Health Corp. is Tier 1 Industry Issuer listed on TSX Venture Exchange. Mettrum Ltd., the wholly owned subsidiary of the Company, is a Toronto-based company incorporated under the laws of the Province of Ontario and a licensed producer under the MMPR, which came into effect on October 1, 2013. Mettrum received its first license from Health Canada on November 1, 2013 and began production of medical cannabis on the same date at its first production facility in Bowmanville, Ontario. Mettrum received its second license from Health Canada on December 11, 2014 for its acquired Agripharm facility in Clearview, Ontario. With the Company's two licenses, Mettrum is a leading producer and vendor of medical marijuana under the MMPR system.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the results of operations. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company and Mettrum disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this Press release.

Contact Information